We are live on ! Find out more
KYTH

KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH

Delisted

KYTH was delisted on the 30th of September, 2015.

Back to rankings

102 hedge funds and large institutions have $704M invested in KYTHERA BIOPHARMACEUTICALS, INC COM in 2014 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 45 increasing their positions, 28 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

71% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 14

61% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 28

20% more capital invested

Capital invested by funds: $589M → $704M (+$116M)

11% more funds holding

Funds holding: 92 → 102 (+10)

10% more call options, than puts

Call options by funds: $800K | Put options by funds: $724K

Holders
102
Holders Change
+10
Holders Change %
+10.87%
% of All Funds
2.95%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
24
Increased
45
Reduced
28
Closed
14
Calls
$800K
Puts
$724K
Net Calls
+$76K
Net Calls Change
-$1.06M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$46M
2
PCM
Pentwater Capital Management
Florida
+$17.4M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$10.4M
4
PHS
PFM Health Sciences
California
+$7.68M
5
BFA
BlackRock Fund Advisors
California
+$6.26M

Top Sellers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$12.3M
2
Millennium Management
Millennium Management
New York
-$9.61M
3
WRF
Waddell & Reed Financial
Kansas
-$8.91M
4
Ameriprise
Ameriprise
Minnesota
-$6.07M
5
RG
Redmile Group
California
-$5.12M
Name Holding Trade Value Shares
Change 		Change in
Stake
JP Morgan Chase
26
JP Morgan Chase
New York
$4.75M +$4.63M +103,524 +651%
Allianz Asset Management
27
Allianz Asset Management
Germany
$4.68M – – –
Renaissance Technologies
28
Renaissance Technologies
New York
$4.63M +$3.36M +75,200 +183%
EAM
29
Eagle Asset Management
Florida
$4.03M +$4.53M +101,287 New
SAM
30
Senzar Asset Management
New York
$3.56M +$470K +10,500 +13%
AC
31
Ascend Capital
California
$3.42M +$237K +5,307 +7%
Lord, Abbett & Co
32
Lord, Abbett & Co
New Jersey
$3.37M -$2.09M -46,814 -36%
Loomis, Sayles & Company
33
Loomis, Sayles & Company
Massachusetts
$3.26M +$3.67M +81,973 New
GC
34
Guggenheim Capital
Illinois
$3.15M +$3.55M +79,342 New
BNP Paribas Asset Management
35
BNP Paribas Asset Management
France
$3.11M -$91.9K -2,054 -3%
CCM
36
Cadian Capital Management
New York
$2.98M +$3.36M +75,000 New
Geode Capital Management
37
Geode Capital Management
Massachusetts
$2.73M +$233K +5,202 +8%
Deutsche Bank
38
Deutsche Bank
Germany
$2.6M +$787K +17,593 +37%
FM
39
Forward Management
California
$2.53M +$268K +5,982 +9%
Wells Fargo
40
Wells Fargo
California
$2.35M +$914K +20,421 +53%
TAM
41
Tocqueville Asset Management
New York
$2.25M +$374K +8,350 +17%
TCIM
42
TIAA CREF Investment Management
New York
$2.15M -$49.7K -1,110 -2%
DCM
43
Driehaus Capital Management
Illinois
$2.11M -$694K -15,525 -23%
BCM
44
BBT Capital Management
Texas
$1.99M -$671K -15,000 -23%
California State Teachers Retirement System (CalSTRS)
45
California State Teachers Retirement System (CalSTRS)
California
$1.91M +$1.19M +26,669 +125%
PIM
46
Partner Investment Management
California
$1.57M +$586K +13,104 +50%
Mackenzie Financial
47
Mackenzie Financial
Ontario, Canada
$1.45M -$90.3K -2,019 -5%
GACM
48
Green Arrow Capital Management
New York
$1.39M -$895K -20,000 -36%
Ameriprise
49
Ameriprise
Minnesota
$1.3M -$6.07M -135,728 -81%
BIM
50
BlackRock Investment Management
Delaware
$1.3M +$11.2K +250 +0.8%
1
2
3 4 5

KYTH Hedge Fund Activity: Q1 2014 in Review

102 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) for Q1 2014, worth a combined $704M — up 20% from $589M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new KYTH positions and 14 closed out — a net gain of 10 holders — while 45 added to existing stakes and 28 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $46M. The largest seller was Adage Capital Partners, cutting an estimated $12.3M.

  • 102 institutional investors held KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) as of Q1 2014, up from 92 in Q4 2013.
  • Funds reported $704M of KYTHERA BIOPHARMACEUTICALS, INC COM stock for Q1 2014, up 20% quarter-over-quarter.
  • 24 funds opened new KYTHERA BIOPHARMACEUTICALS, INC COM positions in Q1 2014 and 14 closed out, a net change of +10 holders.
  • The largest KYTHERA BIOPHARMACEUTICALS, INC COM buyer in Q1 2014 was Fidelity Investments, an estimated $46M added.
  • The largest KYTHERA BIOPHARMACEUTICALS, INC COM seller in Q1 2014 was Adage Capital Partners, an estimated $12.3M sold.

Based on aggregated 13F filings for Q1 2014.